[1]Gemma,Sandra;Camodeca,Caterina;Brindisi,Margherita;Brogi,Simone;Kukreja,Gagan;Kunjir,Sanil;Gabellieri,Emanuele;Lucantoni,Leonardo;Habluetzel,Annette;Taramelli,Donatella;Basilico,Nicoletta;Gualdani,Roberta;Tadini-Buoninsegni,Francesco;Bartolommei,Gianluca;Moncelli,MariaRosa;Martin,RowenaE.;Summers,RobertL.;Lamponi,Stefania;Savini,Luisa;Fiorini,Isabella;Valoti,Massimo;Novellino,Ettore;Campiani,Giuseppe;Butini,Stefania[JournalofMedicinalChemistry,2012,vol.55,#23,p.10387-10404]
[2]CurrentPatentAssignee:INNOVSTONETHERAPEUTICS-WO2022/161420,2022,A1Locationinpatent:Page/Pagecolumn57
[3]CurrentPatentAssignee:ELILILLY&CO-WO2007/28083,2007,A2Locationinpatent:Page/Pagecolumn92-93
[4]CurrentPatentAssignee:ASTRAZENECAPLC-US6777561,2004,B1Locationinpatent:Pagecolumn34
[1]Shi,Xiaonan;Chen,Xi;Wang,Muhua;Zhang,Xinying;Fan,Xuesen[JournalofOrganicChemistry,2018,vol.83,#12,p.6524-6533]
[2]CurrentPatentAssignee:HENANNORMALUNIVERSITY-CN108503572,2018,ALocationinpatent:Paragraph0085-0087
[1]ChemSusChem,2019,vol.12,p.3801-3807
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101